Firm begins study of sepsis detection device

09/12/2013 | MassDevice.com (Boston)

T2 Biosystems has kicked off a clinical study of its T2Candida test, which is used to detect a fungus often linked to hospital-acquired infections that can trigger sepsis. Data from the trial will be used to support the company's regulatory application for the assay, which takes just about three hours to spot a single colony-forming unit of the Candida fungus in a 1-milliliter blood sample.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC